Skip to main content
OpenTrials

Clinical trial condition

Refractory Primary Mediastinal Large B-Cell Cell Lymphoma

Explore clinical trials studying Refractory Primary Mediastinal Large B-Cell Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Refractory Primary Mediastinal Large B-Cell Cell Lymphoma trial results

Completed

Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy

NCT04703686

Conditions
Diffuse Large B-cell Lymphoma Refractory, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • CHU Amiens Picardie Site sud Amiens, France
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • Hopital Henri Mondor Créteil, France
  • CHU de Dijon - Hôpital le Bocage Dijon, France
View all 19 locations
View Trial Details

Related conditions